Measuring antibiotic prescribing in hospitalised children in resource-poor countries: a systematic review

Adam Irwin1, Mike Sharland

  • 1Institute of Child Health, Alder Hey Children's Hospital NHS Foundation Trust, Department of Women's and Children's Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK. adam.irwin@liverpool.ac.uk

Insights

Hospitalized children in resource-poor countries face high antibiotic exposure, contributing to resistance. Standardized methods are needed to track antibiotic use and inform global health strategies.

Area of Science:

  • Global Health
  • Infectious Diseases
  • Pharmacology

Background:

  • Antibiotic resistance is a major global health threat driven by widespread antibiotic use.
  • Understanding antibiotic exposure in hospitalized children, especially in resource-poor settings, is crucial but limited.
  • Infectious diseases disproportionately affect children in resource-limited regions.

Purpose of the Study:

  • To systematically review and quantify antibiotic use in hospitalized children in resource-poor countries.
  • To identify gaps in research methodology and data collection regarding pediatric antibiotic exposure.
  • To highlight the need for standardized surveillance of antimicrobial prescribing.

Main Methods:

  • Systematic literature search across multiple databases (MEDLINE, CINAHL, EMBASE, LILACS, African Index Medicus).
  • Inclusion of original research studies quantifying antibiotic use in hospitalized children.
  • Analysis of methodologies, with a focus on the use of defined daily dose (DDD).

Main Results:

  • Eighteen relevant studies were identified, exhibiting considerable methodological variation.
  • Only seven studies utilized a recognized defined daily dose (DDD) methodology.
  • Hospitalized children in these settings demonstrated high exposure to antibiotics.
  • Data quality and comparability were limited, particularly outside of China.

Conclusions:

  • There is a significant lack of standardized data on antibiotic use in hospitalized children in resource-poor countries.
  • A simplified, standardized pediatric DDD methodology is essential for international comparison and surveillance.
  • Establishing an international surveillance network for antimicrobial prescribing and resistance is a critical goal.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Antibiotic Selection00:57

Antibiotic Selection

Overview